SCYNEXIS (SCYX) Stock Forecast for 2023 – 2026. Sell or Buy?
Updated: November 29, 2023 (07:14)Sector: Healthcare
The share price of SCYNEXIS, Inc. (SCYX) now
50/200 Day Moving Average: $1.697 / $2.146
This figure corresponds to the Average Price over the previous 50/200 days. For SCYNEXIS stocks, the 50-day moving average is the resistance level today.
For SCYNEXIS stocks, the 200-day moving average is the resistance level today.
Are you interested in SCYNEXIS, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the SCYNEXIS stock price in 2023, 2024, 2025, 2026, 2027. How much will one SCYNEXIS share be worth in 2023 - 2027?
When should I take profit in SCYNEXIS stock? When should I record a loss on SCYNEXIS stock? What are analysts' forecasts for SCYNEXIS stock? What is the future of SCYNEXIS stock? We forecast SCYNEXIS stock performance using neural networks based on historical data on SCYNEXIS stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
SCYNEXIS stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for SCYNEXIS shares. This happens once a day.
Historical and forecast chart of SCYNEXIS stock
The chart below shows the historical price of SCYNEXIS stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the SCYNEXIS stock price can be found in the table below.
Long-term forecasts by years.
SCYNEXIS Inc is a pharmaceutical company dedicated to the discovery, development and commercialization of new antibacterial agents to meet unmet therapeutic needs.
SCYNEXIS daily forecast for a month
SCYNEXIS Daily Price Targets
SCYNEXIS Stock Forecast 12-01-2023.
Forecast target price for 12-01-2023: $1.59.
Positive dynamics for SCYNEXIS shares will prevail with possible volatility of 5.068%.
Pessimistic target level: 1.53
Optimistic target level: 1.62
SCYNEXIS Stock Forecast 12-02-2023.
Forecast target price for 12-02-2023: $1.63.
Positive dynamics for SCYNEXIS shares will prevail with possible volatility of 4.737%.
Pessimistic target level: 1.59
Optimistic target level: 1.66
SCYNEXIS Stock Forecast 12-03-2023.
Forecast target price for 12-03-2023: $1.60.
Negative dynamics for SCYNEXIS shares will prevail with possible volatility of 4.537%.
Pessimistic target level: 1.58
Optimistic target level: 1.66
SCYNEXIS Stock Forecast 12-04-2023.
Forecast target price for 12-04-2023: $1.57.
Negative dynamics for SCYNEXIS shares will prevail with possible volatility of 2.849%.
Pessimistic target level: 1.54
Optimistic target level: 1.59
SCYNEXIS Stock Forecast 12-05-2023.
Forecast target price for 12-05-2023: $1.54.
Negative dynamics for SCYNEXIS shares will prevail with possible volatility of 4.191%.
Pessimistic target level: 1.51
Optimistic target level: 1.58
SCYNEXIS Stock Forecast 12-06-2023.
Forecast target price for 12-06-2023: $1.52.
Negative dynamics for SCYNEXIS shares will prevail with possible volatility of 4.991%.
Pessimistic target level: 1.49
Optimistic target level: 1.57
SCYX (SCYX) Monthly Stock Prediction for 2023
SCYNEXIS forecast for this year
SCYNEXIS Stock Prediction for Dec 2023
An uptrend is forecast for this month with an optimal target price of $1.59278. Pessimistic: $1.35. Optimistic: $1.72
SCYNEXIS (SCYX) Monthly Stock Prediction for 2024
SCYNEXIS (SCYX) Monthly Stock Prediction for 2025
SCYNEXIS (SCYX) Monthly Stock Prediction for 2026
SCYNEXIS (SCYX) Monthly Stock Prediction for 2027
SCYNEXIS information and performance
1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, US
Market capitalization of the SCYNEXIS, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of SCYX shares in the company outstanding by the market price of one share.
EBITDA of SCYNEXIS is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
SCYNEXIS (SCYX) stock dividend
SCYNEXIS last paid dividends on 01/01/1970. The next scheduled payment will be on 07/17/2020. The amount of dividends is $0 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.